Alnylam Pharmaceuticals (NasdaqGS:ALNY) Update / briefing Transcript

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Update / briefing March 24, 2026 09:30 AM ET Company ParticipantsChristine Akinc - Chief Corporate Communications OfficerJohn Kennedy - SVP and TTR Franchise Commercialization LeadMark Soued - SVP, Head of U.S., and TTR LeadSameer Bansilal - VP of Global Medical Affairs and Head of TTR Disease AreaTolga Tanguler - Chief Commercial Officer and EVPTolga TangulerGood morning, everyone, and thank you for joining us today. I'm Tolga Tanguler, Chief Commercial Officer at Al ...